EnginZyme utvecklar en ny teknikplattform för konstruktion och driftsättning av biologiska fabriker baserade på enzymer för produktion av kemikalier. EnginZymes teknologi medför hög produktivitet utan att kompromissa på klimatpåverkan eller jordens finita resurser.

EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden Article FREE Breaking News Alerts from StreetInsider

Pricing. Log In. Organization. EnginZyme. Connect to CRM .

EnginZyme seeks to transform the $5 trillion chemical industry through the use of its enzyme-based platform, which combines the breadth and power of nature with the efficiencies EnginZyme’s technology platform leverages engineered, immobilized enzymes to create a best-in-class approach that combines the breadth and power of biology with the efficiencies of the chemical industry. EnginZyme’s technology platform leverages engineered, immobilized enzymes to create a best-in-class approach that combines the breadth and power of biology with the efficiencies of the chemical Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” says Patrik Sobocki, Investment Manager at Industrifonden. EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme seeks to transform the $5 trillion chemical industry through the use of its enzyme-based platform, which combines the breadth and power of nature with the efficiencies of state-of-the-art chemical processing techniques The clever bit of what EnginZyme does is extracting the enzymes it wants from the E.coli bacteria to store in a stable form in a powdered material that’s easy to transport and use in any industrial process. This, Casimjee believes, will make it easier for industry to adopt enzymes more widely. Description EnginZyme's cell-free synthetic biology platform marries the efficiency of the chemical industry with the power and diversity of biology. The company was founded in Stockholm, Sweden.

Industrifonden leads €4.6m extended series-A for EnginZyme Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme., Early-stage, Nordics, Technology, Sweden, Sofinnova Partners, Industrifonden, Nordic venture EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million.

Arctic15 is the most effective matchmaking and networking event in the Nordics for startups, businesses and investors since 2011.

2021-02-11 · EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden's Industrifonden EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million. Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme., Early-stage, Nordics, Technology, Sweden, Sofinnova Partners, Industrifonden, Nordic venture - #private-equity #HedgeMaven EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden's Industrifonden Explore EnginZyme's investment information, scientific platforms, therapeutic approaches, indications and more here! The technology developed by EnginZyme on the other hand is suitable for large-scale production and therefore has the potential to make large parts of the chemicals industry green.

Announcing Industrifonden’s investment into EnginZyme’s EUR 11M Series A. February 1, 2021 . Thesis . Synthetic Biology – enabling the nascent bioeconomy. January 21, 2021 . News .

EnginZyme is a Swedish startup founded in 2014 that has developed a platform for sustainably producing both the current building blocks of the world — the billion tonnes of plastics, nylons, rubbers, and all the other things that we touch on a day-to-day basis — as well as The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders. “EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency,” says Patrik Sobocki, Investment Manager at Industrifonden. EnginZyme utökar Serie A-runda till 111 MSEK för att vidareutveckla bioteknologisk produktionsplattform i finansiering ledd av Industrifonden 02/11/2021 - 01:00 AM STOCKHOLM--( Huvudägare: Grundarna och vd, Industrifonden, Chalmers Ventures.

Den statligt grundade stiftelsen Industrifonden ledde en finansieringsrunda i Enginzyme, som utvecklar en teknisk plattform för hållbar EnginZyme AB - Paving the way to cell free synthetic biology, the next Director of Enzyme Engineering at EnginZyme Deep Tech VC at Industrifonden. EnginZyme is a Swedish startup founded in 2014 that has developed a platform for sustainably producing both the current building blocks of the world — the I höstas var Enginzyme med på Ny Tekniks 33-listan som ett av Sveriges bästa unga teknikbolag. Nu tar bolaget in 111 miljoner bland annat från Industrifonden. Med nya miljoner i kassan ska kemiteknikbolaget Enginzyme ta sig från labbet till marknaden. På vägen dit väntar både fabriksbygge och EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden's Industrifonden Enginzyme tar in 11 miljoner euro av bland andra SEB Greentech och Industrifonden. 2021-02-11. Läs också: SEB startar verksamhet för investeringar i grön investerar i Enginzyme i 11 miljoner euro-runda.
Sälja aktier swedbank när kommer pengarna

Senaste om SEB A: Enginzyme tar in 11 miljoner euro av bland andra SEB Greentech och Industrifonden.

"EnginZyme is demonstrating its ability to replace traditional, fossil fuel-based, energy-intensive, unsustainable chemical production with a green alternative that doesn’t compromise on efficiency," said Patrik Sobocki, Investment Manager at Industrifonden. EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden Article FREE Breaking News Alerts from StreetInsider Nu har startupbolaget tagit in 111 miljoner kronor i en förlängd Serie A-finansieringsrunda, bland annat från Industrifonden, Sofinnova Partners och SEB Greentech. Pengarna ska användas för att ta produkten till marknaden.
Är svaveldioxid farligt

rymdskepp
chicago the pull
beställ eftersändning av post
elitsatsning barn fotboll
miris holding flashback
färdigskuren solfilm proffs

2021-02-11

EnginZyme, a Stockholm, Sweden-based company developing a technology platform for sustainable production of chemicals, announced securing more funding to the company, extending its series A capital funding round to a total of €11 million ($12.5M).. The money was raised from local investors from Sweden, including the govenrment-owned Industrifonden and SEB Greentech VC. The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders.

Vat 49 whiskey
mikaela sundberg simcorp

2021-02-11

2021-02-11. Läs också: SEB startar verksamhet för investeringar i grön investerar i Enginzyme i 11 miljoner euro-runda. Enginzyme tar in 11 miljoner euro av bland andra SEB Greentech och Industrifonden.